Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialNEAL FRANZ, David; BELOUSOVA, Elena; CURATOLO, Paolo et al.Lancet (British edition). 2013, Vol 381, Num 9861, pp 125-132, issn 0140-6736, 8 p.Article

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trialBISSLER, John J; CHRISTOPHER KINGSWOOD, J; WHITTEMORE, Vicky H et al.Lancet (British edition). 2013, Vol 381, Num 9869, pp 817-824, issn 0140-6736, 8 p.Article